2011 Speakers

Dr. Anthony Wong, MD, PhD

Professor of Clinical Toxicology - University of Sao Paulo Director - Maxilabor Diagnosticos
Brazil

Graduated in Medicine in 1972 with a PhD in Clinical Toxicology (Use of Drugs in Pregnancy). Medical Director of Maxilabor since 1999 (Maxilabor performs drug testing in Brazil and Latin America for over 120 companies and is the major stakeholder in Drug Prevention Programs in Brazil, providing expertise for government, industry and academia). Chief of CEATOX Poison Control Centre and Drug Safety Programme of WHO.

Dr. Benjamin Gerson, MD, MRO

University Services PA
USA

Dr. Gerson is Medical Director of University Services, a private healthcare organization that provides MRO and other drug testing support services. He is Board Certified in Anatomic & Clinical Pathology, in Toxicology and also is Board Certified as an MRO and is an Officer of the Board of Directors of MROCC, which certifies MROs. His academic career has been at Harvard Medical School, Boston University School of Medicine, and Jefferson Medical College.

Bill Corl

Omega Laboratories
USA

Bill Current

WFC & Associates
USA

Bill Current is the president and founder of WFC & Associates, a national consulting firm based in Florida that specializes in drug testing policy development and providing accurate and up-to-date state drug testing law information.

Mr. Current is the former Executive Director of the American Council for Drug Education and was the first Director of the Institute for a Drug-Free Workplace. He served as Vice President of Consulting for a national third-party administrator of drug testing and background screening services. He founded WFC & Associates in 1999. He is the author or co-author of 10 books on substance abuse issues, including Why Drug Testing? He also edits and publishes The On-Line Ultimate Guide to State Drug Testing Laws.

Bon Idziak

Applicant Insight
USA

Bon Idziak is the CEO of Applicant Insight, Inc. Bon is a 12 year industry professional and subject matter expert on the topics of Background Screening, Drug Testing, Technology Solutions and Paperless Workflow. Well versed in policy, procedure and compliance, Bon is frequently asked to share his expertise at conferences, in educational settings, with industry publications and through various media outlets. Bon regularly consults with major national employers and associations to develop employment screening solutions that are cost-effective, compliant and address corporate goals and regulatory requirements.

Bon also sits on the Board of Directors for the Substance Abuse Program Administrator’s Association. Since its inception 20 years ago, Applicant Insight has actively promoted drug and alcohol testing to employers of all types with a unique focus on serving companies with a regulatory requirement to test. Bon has been an active participant in the Substance Abuse Program Administrators Association for many years. Applicant Insight is CTPA Certified through the SAPAA certification program and supports the efforts of SAPAA to promote education, consistency and best practices throughout the industry.

Bon is also a member of the Society for Human Resource Management, American Society for Industrial Security, Drug and Alcohol Testing Industry Association, Securities and Insurance Licensing Association, and the National Association of Professional Background Screeners (NAPBS). He is an active participant and contributor to the NAPBS Government Affairs Committee. Bon’s client-focused philosophy is to minimize hiring and retention risk through the design, implementation and management of an intelligent screening program built to ensure compliance with regulating agencies governing the use of background checks and substance abuse screening in the workplace.

Dr. Christine Moore PhD, DABCC

Immunalysis Corporation
USA

• Over 20 years of experience in forensic toxicology, developing analytical procedures for the determination of drugs in oral fluid, blood, meconium and hair
• Board certified by the American Board of Clinical Chemistry; Fellow of the Royal Society of Chemistry
• Past-President of the Society of Forensic Toxicologists; Vice-President of the Society of Hair Testing
• Over 100 peer-reviewed publications in forensic toxicologyOral Fluid Testing: Gaining Acceptance Across the Globe

Colin Woods

DISA
USA

Colin started with DISA in 2002. He has over 12 years of sales management experience, including four years with Kraft Foods. Colin is responsible for all aspects of the Sales Operations Department including new business development and key account sales. He plays a lead role in the development and implementation of DISA's Employee Screening services, and is instrumental in the ongoing success and expansion of the DISA Contractors Consortium. Colin is a graduate of University of Kansas with a BBA in Business Administration.

Dr. David M. Batey

Exxon Mobil Corporation

Douglas Martin, MD

St. Luke's Center for Occupational Health Excellence
USA

Dr. Douglas W Martin has been the Chair of the Medical Review Officer Section of the American College of Occupational & Environemental Medicine for 10 years. In that capacity he has authored ACOEM position statements on drug and alcohol testing and has written comments for federal regulatory proposed changes. Although he is involved frequently with federal workplace drug testing issues, his main interest lies in the non-federal drug testing arena and more recently has been an advocate for an expanded testing panel to deal with the burgeoning problem in the United States with misuse and abuse of presciption medication and its impact on workplace and public safety.

Elizabeth A. Jennison

Honeywell

Jerry Crosby

Head of International Employer Solutions, Quest Diagnostics Inc.
USA (China, India, Mexico)

Mr. Crosby received his Bachelors of Science degree in Biology from St. Joseph's University and a Masters Degree in Environmental Health/Industrial Toxicology from Temple University. Mr. Crosby has over 26 years of experience in the clinical laboratory industry. In 2007, Quest Diagnostics opened a new laboratory in Gurgaon India and Mr. Crosby was responsible for developing and growing the Employer line of business in India.

Josephine Kenney

Senior VP of Compliance - First Advantage Employment Screening Services Division, Occupational Health Group
USA

Josephine Elizabeth Kenney is the Senior Vice President of Compliance and Senior Compliance Counsel for First Advantage. Josephine is responsible for regulatory compliance and support across First Advantage product lines and has significant experience in the workplace drug testing industry. First Advantage, a talent acquisition solutions provider, offers companies around the globe solutions to improve their decision making and process for talent acquisition across the employment continuum. Custom tailored for each client, its solutions address recruiting, applicant tracking, screening and assessment, on-boarding, hiring tax credits and re-screening, among others.

Josephine has spoken at two International Forums, published several articles on international workplace drug testing, and Chairs the Substance Abuse Program Administrator Association’s (SAPAA’s) International Committee.

Kurt Bothner

Vice President - Compliance Information Systems
USA

Kurt S. Bothner is Vice President over Sales, Marketing and Customer Service for Compliance Information Systems. Kurt has spent 17 years with CIS helping to design and build applications that cater to the drug and alcohol testing industry. Prior to joining CIS, Mr. Bothner spent eight years in business development and financial management with Bank of America Corporation in San Francisco, CA. He earned a Bachelor’s degree in Economics from University of California at Davis, and holds a Masters degree in Finance from the University of San Francisco. Kurt and his family, including three children, very much enjoy the outdoor lifestyle offered by Utah, and take advantage of the myriad of winter and summer recreational activities throughout the state.

Marilyn Carroll

Chevron

Marilyn Roach

Shell Oil
USA

Marilyn has been employed by Shell Oil Company for 22 years and has spent 20 of those years working with Shell's Substance Abuse Program. She is responsible for managing drug and alcohol testing programs governed by the Department of Transportation (DOT) and corporate policies. In the past 18 years while managing these programs, she has gained an extensive knowledge of all aspects of the drug and alcohol testing programs and played a key role in the design and changes to the company’s policy over the years. She is a Registered Nurse in the State of Texas, Certified Occupational Health Nurse, Certified Employee Assistance Professional, Certified Substance Abuse Program Administrator, and Certified Case Manager.

Melissa Ray

Dräger

Michael Wheeldon

Integrity Sampling
Australia

Michael Wheeldon is the founding Managing Director of Integrity Sampling (Aust) Pty Ltd, a national company that specializes in formulating drug and alcohol policies and procedures, education, awareness and drug and alcohol testing.

Michael Wheeldon served as a member of the Victoria Police for 20 years before entering the private sector as an investigator incorporating risk management. This in turn led to the formation of Integrity Sampling and it becoming a forerunner in the field of workplace oral fluid drug testing throughout Australia.

Michaela Neuhofer

Greiner Bio-One International
Austria and Switzerland

Since 2008 Mrs. Neuhofer is product manager for Saliva Systems at the company Greiner Bio-One GmbH (Austria). Prior to joining GBO Mrs. Neuhofer spent 20 years in some of the more notable hospitals in Austria for microbiology and molecular biology testing where she adopted research protocols for routine diagnostic. In 2008 she received her MBA in Social Economics from the Johannes Kepler University in Linz.

Greiner Bio-One International AG is a world market leader in the field of biotechnology, diagnostics, laboratory devices and In Vitro diagnostics. The product group "Preanalytics" offers innovative solutions for specimen collection. Greiner Bio-One revolutionizes saliva analytics through a new, unique collection and quantification system.

Patrice Kelly

Deputy Director
Office of Drug and Alcohol Policy and Compliance
USA

Ms. Kelly has been involved with regulated drug and alcohol testing since 1992. She is the Deputy Director of the United States’ Department of Transportation’s Office of Drug and Alcohol Policy and Compliance (ODAPC). ODAPC’s mission is to enhance public safety within transportation industries across the United States by ensuring that DOT’s drug and alcohol policies are implemented in a consistent, fair and efficient manner. Ms. Kelly has been with ODAPC since October, 2007. Prior to that, she served as the Deputy Division Manager of the Drug Abatement Division, Office of Aerospace Medicine, at the Federal Aviation Administration (FAA). Ms. Kelly was the first FAA attorney to revoke an air carrier’s certificate for failure to implement drug and alcohol testing, and she initiated the FAA’s first civil penalty cases enforcing the drug and alcohol testing regulations. Ms. Kelly has also served as the Senior Attorney for Aerospace Medical Issues in the Regulations Division of the FAA Chief Counsel’s Office. She has worked extensively on all changes to the FAA’s and ODAPC’s drug and alcohol regulations since 1996.

A graduate of Boston College, and a member of the Phi Beta Kappa Society, Ms. Kelly received a Juris Doctor degree from Georgetown University Law Center. She is admitted to the District of Columbia and Pennsylvania Bars. Ms. Kelly worked for the Supreme Court of the United States, and later for law firms in Washington, DC, representing transportation entities and associations, before beginning her career with the FAA.

Patricio Labatut H.

DATIA
Chile, Argentina & Colombia

Patricio Labatut is the co-founder and Executive Director of Global Partners, a national firm that specializes in implementing Drug Free Workplace Programs (DFWP) at South American countries which include A&D policy, legal aspects, workshops, and drug testing.

Mr. Labatut currently serves as a member of the Drug and Alcohol Testing Industry Association (DATIA) Board of Directors. Besides he is Chairman of the International Committee of DATIA. He also served as Vice President of consulting companies and Manager for foreign investments and insurance instruments in Citibank, Santander Bank, among others.

Per Björklöv

CEO - Drugtest Scandinavia
Sweden

Per lives in Stockholm, Sweden. He studies at University of Stockholm (teaching, information and marketing) and University of Uppsala, (Biology and Geography). Worked between 1991 and 2005 at Department of Pharmacology at Huddinge University Hospital in Stockholm, with the project "workplace drug testing" and doping. Started DrugtestScandinavia 2006.

Organized the first European symposium on Drug testing at Workplace 1998 and also co-founder of European Workplace Drug Testing Society (EWDTS). Was the president of EWDTS between 2000 – 2005 and is now chairing the guideline committee. Per is also the initiator and founder of IFDAT.

Robert Schoening

United States Coast Guard
USA

Ronald Agius

LaborKrone Germany
Germany

Rosario Magos

Omega Laboratories Inc.
Mexico

College degree on Biochemistry from UNAM, BS graduated on Art Graphics (Concentration in Administration, Technological Lab and Chemical Analysis) Course Completion on Legal dispositions on the Graphic Sector Training Program Former Parent Coordinator for The Department of Health and Developmental Services (2000-2007) . Served as a liaison for foreign customers on business with US 12 years Experience Reviewing, Preparing and Translating Company Compliance with all applicable laws and procedures on foreign countries to facilitate service contracts. 10 years experience as an Agent between Omega Laboratories Inc. and Mexican Energy Industry performing Hair Analysis for Drug Detection.

Sue Nolan 

Forensic Toxicologist and Company Director, DrugFree Sites
New Zealand

Sue Nolan has been a forensic scientist and regular expert witness for 35+ years specializing in illicit drugs and toxicology. She established her own consultancy company, DrugFree Sites, in November 2007 but prior to that was employed by the Institute of Environmental Science and Research Ltd (ESR) and the Department of Scientific and Industrial Research (DSIR). Since 1992 Sue has advised over 1500 New Zealand companies on developing and implementing Drug and Alcohol Free Workplace Policies and Programmes and has published and presented regularly.

As a member, since 1995, of the joint Australian/New Zealand Standards Technical Committee CH-036, Sue has been collectively responsible for preparing the Standard AS/NZS 4308 including the 2008 version “Procedure for specimen collection and the detection and quantitation of drugs of abuse in urine.” She was instrumental in establishing New Zealand's first AS/NZS 4308 accredited laboratory for workplace drug testing, ESR, in 2003.